About this trial
This project will investigate the effects of alternative nicotine products on smoking, weight gain, and related outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
body mass index (BMI) ≥ 30 kg/m2 (i.e., obese)
smoked ≥ 5 cigarettes/day during the past year
21 or older (due to minimum legal age EC restrictions)
exhaled breath carbon monoxide (CO) level > 6 ppm at Baseline (BL) (to confirm self-reported smoking)
Disqualifiers
received smoking cessation treatment of any kind in the past 30 days (actively quitting smoking),
currently using EC or NRT more than 2 days/week (this may affect responses to study-supplied products)
hospitalized for mental illness in past 30 days
heart-related event (e.g., heart attack, severe angina) in past 30 days
Trial design
Parallel
Treatments tested in this trial
Electronic Cigarettes (EC)
Other interventionParticipants will receive information about the comparative risk of alternative nicotine products relative to smoking and will be asked to switch to EC for 8 weeks, with EC provided.
Nicotine replacement therapy (NRT)
Other interventionParticipants will receive information about the comparative risk of alternative nicotine products relative to smoking and will be asked to switch to combination NRT (transdermal + oral) for 8 weeks, with NRT provided.
Treatment groups
Trial outcomes
Primary outcomes
number of cigarettes per day
Daily use of cigarettes will be determined using the Timeline Follow-Back (TLFB) in follow-up assessments.
carbon monoxide (CO)
Exhaled breath sample used to measure carbon monoxide
number of quit attempts
Number of attempts to quit smoking during the experimental period
Secondary outcomes
product acceptability
Self-rated acceptability (e.g., satisfaction) of the alternative nicotine product assigned (if applicable)
product adherence
Percentage of days using the alternative nicotine product assigned (if applicable)
change in weight
change in body weight (lbs) from baseline to 2 months
change in waist circumference
change in waist circumference, a measure of central adiposity, from baseline to 2 months
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Brown University
Lead sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator